专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20080021094A1 TREATMENTS FOR NEUROGENETIC DISORDERS, IMPULSE CONTROL DISORDERS, AND WOUND HEALING 有权
标题翻译：治疗神经病变，麻醉控制疾病和创伤治疗
公开(公告)号：US20080021094A1
公开(公告)日：2008-01-24
申请号：US11830906
申请日：2007-07-31
申请人： Nathan Shapira , Mary Lessig , Daniel Driscoll
发明人： Nathan Shapira , Mary Lessig , Daniel Driscoll
IPC分类号： A61K31/357 , A61K31/255 , A61P17/02 , A61P25/00 , A61K31/35
CPC分类号： A61K31/00 , A61K31/18 , A61K31/255 , A61K31/35 , A61K31/351 , A61K31/357 , A61K31/7024
摘要： The subject invention provides methods and compositions for the treatment of neurogenetic disorders, particularly DSM-IV impulse control disorders such as intermittent explosive disorder, kleptomania, pyromania, pathologic gambling, trichotillomania, and other impulse control disorders such as compulsive buying and problematic Internet use. In a preferred embodiment, the subject invention provides methods for treating or controlling symptoms associated with ADHD or PWS comprising the administration of therapeutically effective amounts of compositions containing compounds of the formulas I-V. In another embodiment, the subject invention provides for methods of promoting wound healing comprising the administration of a therapeutically effective amount of a composition comprising the compounds of formulas I-V. Compositions may administered to a wound site via a salve, ointment, or as a component of a bandage or bioadhesive applied to the site of injury. The invention also provides therapeutically effective compositions comprising one or more of the compounds of formulas I-V.
摘要翻译：本发明提供了用于治疗神经源性疾病，特别是DSM-IV脉冲控制障碍（例如间歇性爆发性疾病，克雷帕托尼亚，pyromania，病理性赌博，拔毛病等）和诸如强迫性购买和有问题的因特网使用的其它冲动控制障碍的方法和组合物。在一个优选的实施方案中，本发明提供了治疗或控制与ADHD或PWS相关的症状的方法，包括施用治疗有效量的含有式I-V化合物的组合物。在另一个实施方案中，本发明提供促进伤口愈合的方法，包括施用治疗有效量的包含式I-V化合物的组合物。组合物可以通过药膏，软膏或作为施用于损伤部位的绷带或生物粘合剂的组分施用于伤口部位。本发明还提供包含一种或多种式I-V化合物的治疗有效组合物。

2. 发明申请

US20050101543A1 Treatments for neurogenetic disorders, impulse control disorders, and wound healing 审中-公开
标题翻译：治疗神经源性疾病，冲动控制障碍和伤口愈合
公开(公告)号：US20050101543A1
公开(公告)日：2005-05-12
申请号：US11013259
申请日：2004-12-15
申请人： Nathan Shapira , Mary Lessig , Daniel Driscoll
发明人： Nathan Shapira , Mary Lessig , Daniel Driscoll
IPC分类号： A61K31/00 , A61K31/18 , A61K31/255 , A61K31/35 , A61K31/351 , A61K31/7024 , A61P17/02 , A61P25/00 , A61K31/70 , A61K31/36
CPC分类号： A61K31/00 , A61K31/18 , A61K31/255 , A61K31/35 , A61K31/351 , A61K31/357 , A61K31/7024
摘要： The subject invention provides methods and compositions for the treatment of neurogenetic disorders, particularly DSM-IV impulse control disorders such as intermittent explosive disorder, kleptomania, pyromania, pathologic gambling, trichotillomania, and other impulse control disorders such as compulsive buying and problematic Internet use. In a preferred embodiment, the subject invention provides methods for treating or controlling symptoms associated with ADHD or PWS comprising the administration of therapeutically effective amounts of compositions containing compounds of the formulas I-V. In another embodiment, the subject invention provides for methods of promoting wound healing comprising the administration of a therapeutically effective amount of a composition comprising the compounds of formulas I-V. Compositions may administered to a wound site via a salve, ointment, or as a component of a bandage or bioadhesive applied to the site of injury. The invention also provides therapeutically effective compositions comprising one or more of the compounds of formulas I-V.
摘要翻译：本发明提供了用于治疗神经源性疾病，特别是DSM-IV脉冲控制障碍（例如间歇性爆发性疾病，克雷帕托尼亚，pyromania，病理性赌博，拔毛病等）和诸如强迫性购买和有问题的因特网使用的其它冲动控制障碍的方法和组合物。在一个优选的实施方案中，本发明提供了治疗或控制与ADHD或PWS相关的症状的方法，包括施用治疗有效量的含有式I-V化合物的组合物。在另一个实施方案中，本发明提供促进伤口愈合的方法，包括施用治疗有效量的包含式I-V化合物的组合物。组合物可以通过药膏，软膏或作为施用于损伤部位的绷带或生物粘合剂的组分施用于伤口部位。本发明还提供包含一种或多种式I-V化合物的治疗有效组合物。

3. 发明申请

US20070191288A1 Treatments for Benign Tumors, Cancers, Neoplasias, and/or Other Inflammatory Disorders or Diseases 审中-公开
标题翻译：良性肿瘤，癌症，肿瘤和/或其他炎性疾病或疾病的治疗
公开(公告)号：US20070191288A1
公开(公告)日：2007-08-16
申请号：US11738577
申请日：2007-04-23
申请人： Nathan Shapira , Mary Lessig , Bonnie McLaurin
发明人： Nathan Shapira , Mary Lessig , Bonnie McLaurin
IPC分类号： A61K31/7024 , A61K31/353 , A61K31/255 , A61K31/335
CPC分类号： A61K31/35 , Y02A50/409 , Y02A50/423
摘要： The subject invention provides methods and compositions for the treatment of benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases. In the practice of the subject invention, an anti-convulsant agent, such as topiramate, is administered to an individual.
摘要翻译：本发明提供了用于治疗良性肿瘤，癌症，肿瘤和/或其它炎性疾病或疾病的方法和组合物。在本发明的实践中，向个体施用抗惊厥药，例如托吡酯。

4. 发明申请

US20050249823A1 Methods for the prevention or amelioration of neuropsychiatric and related diseases 审中-公开
标题翻译：预防或改善神经精神和相关疾病的方法
公开(公告)号：US20050249823A1
公开(公告)日：2005-11-10
申请号：US10975701
申请日：2004-10-28
申请人： Tanya Murphy , Nathan Shapira , Mary Lessig
发明人： Tanya Murphy , Nathan Shapira , Mary Lessig
IPC分类号： A61K31/225 , A61K31/355 , A61K31/525 , A61K33/08
CPC分类号： A61K31/225 , A61K31/355 , A61K31/525 , A61K33/08 , A61K2300/00
摘要： The present invention pertains to compositions and methods for therapeutically and/or prophylactically treating patients with neurological, neurogenetic, or psychiatric diseases, disorders, conditions, or distress. Specifically, the present invention relates to the administration of compositions containing vitamins B6 and E, magnesium oxide, essential fatty acids, and folate.
摘要翻译：本发明涉及用于治疗和/或预防性地治疗患有神经，神经源性或精神疾病，病症或症状的患者的组合物和方法。具体地，本发明涉及给予含有维生素B 6和E，氧化镁，必需脂肪酸和叶酸的组合物。

5. 发明申请

US20050096349A1 Methods to prevent or ameliorate medication-, procedure-or stress-induced cognitive and speech dysfunction and methods to optimize cognitive and speech functioning 审中-公开
标题翻译：预防或改善药物治疗，程序或压力诱发的认知和言语功能障碍的方法以及优化认知和言语功能的方法
公开(公告)号：US20050096349A1
公开(公告)日：2005-05-05
申请号：US10700156
申请日：2003-11-03
申请人： Nathan Shapira , Giselle Mann , April Annis , Toby Goldsmith
发明人： Nathan Shapira , Giselle Mann , April Annis , Toby Goldsmith
IPC分类号： A61K31/137 , A61K31/445
CPC分类号： A61K31/445 , A61K31/137
摘要： Many medications, herbal remedies and procedures have side affects that contribute to cognitive dysfunction. Because of these side effects patients may choose to discontinue medication or treatment (such as ECT) which has a detrimental effect on treatment. Currently, there are no medications approved for helping to alleviate these symptoms. The invention describes a novel treatment for individuals who experience various side effects of cognitive dysfunction. The invention additionally describes how these medications may enhance cognitive function in individuals with normal cognitive functioning who might benefit from this type of enhancement. The subject invention further provides materials and methods for the treatment, prevention, or ameliorate medication-induced cognitive dysfunction comprising the administration of medications or compositions comprising at least one selective norepinephrine reuptake inhibitors (SNR1) and/or buproprion.
摘要翻译：许多药物，草药和手术有副作用，有助于认知功能障碍。由于这些副作用，患者可能会选择停止对治疗有不利影响的药物治疗（如ECT）。目前，没有批准用于帮助缓解这些症状的药物。本发明描述了经历认知功能障碍的各种副作用的个体的新颖治疗。本发明还描述了这些药物如何可以增强具有正常认知功能的个体的认知功能，其可能受益于这种类型的增强。本发明还提供了用于治疗，预防或改善药物诱导的认知功能障碍的材料和方法，其包括施用包含至少一种选择性去甲肾上腺素再摄取抑制剂（SNR1）和/或安非他酮的药物或组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式